Altiok Eda, Ecoiffier Tatiana, Sessa Roberto, Yuen Don, Grimaldo Sammy, Tran Colin, Li David, Rosner Michael, Lee Narae, Uede Toshimitsu, Chen Lu
Vision Science Graduate Program, University of California, Berkeley, California, United States 2Center for Eye Disease and Development, Program in Vision Science, and School of Optometry, University of California, Berkeley, California, United States.
Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6313-9. doi: 10.1167/iovs.15-17509.
We recently reported that corneal lymphatic vessels develop integrin alpha-9 (Itga-9)-positive valves during inflammatory lymphangiogenesis. The purpose of this study was to further investigate the role of Itga-9 in corneal lymphatic valve formation in vivo and lymphatic endothelial cell (LEC) functions in vitro.
Standard murine suture placement model was used to study the effect of Itga-9 blockade on lymphatic valve formation in vivo using Itga-9 neutralizing antibody. Whole-mount corneas were harvested for immunofluorescent microscopic analysis. Additionally, human LEC culture system was used to examine the effect of Itga-9 gene knockdown on cell functions using small interfering RNAs (siRNAs).
Itga-9 blockade in vivo significantly reduced the number of lymphatic valves formed in the inflamed cornea. Moreover, Itga-9 gene knockdown in human LECs suppresses cell functions of proliferation, adhesion, migration, and tube formation.
Itga-9 is critically involved in corneal lymphatic valve formation. Further investigation of the Itga-9 pathway may provide novel strategies to treat lymphatic-related diseases occurring both inside and outside the eye.
我们最近报道,在炎症性淋巴管生成过程中,角膜淋巴管会形成整合素α-9(Itga-9)阳性瓣膜。本研究的目的是进一步研究Itga-9在体内角膜淋巴管瓣膜形成中的作用以及在体外淋巴管内皮细胞(LEC)功能中的作用。
使用标准的小鼠缝线植入模型,用Itga-9中和抗体研究Itga-9阻断对体内淋巴管瓣膜形成的影响。采集全层角膜用于免疫荧光显微镜分析。此外,使用人LEC培养系统,利用小干扰RNA(siRNA)检测Itga-9基因敲低对细胞功能的影响。
体内Itga-9阻断显著减少了炎症角膜中形成的淋巴管瓣膜数量。此外,人LEC中的Itga-9基因敲低抑制了细胞的增殖、黏附、迁移和管腔形成功能。
Itga-9在角膜淋巴管瓣膜形成中起关键作用。对Itga-9途径的进一步研究可能为治疗眼内外发生的淋巴管相关疾病提供新策略。